Abivax Market Cap

Abivax has a market cap or net worth of $992.84 million as of April 26, 2024.

Market Cap

992.84M

Enterprise Value

793.17M

1-Year Change

n/a

Ranking

#2429

Market Cap Chart

Since October 20, 2023, Abivax's market cap has increased from $521.80M to $992.84M, an increase of 90.27%. That is a compound annual growth rate of 246.36%.

Market Cap History

Date	Market Cap	% Change
Apr 26, 2024	993.00M	0.25%
Apr 25, 2024	990.50M	-0.94%
Apr 24, 2024	999.90M	0.18%
Apr 23, 2024	998.10M	1.08%
Apr 22, 2024	987.40M	2.49%
Apr 19, 2024	963.40M	1.31%
Apr 18, 2024	950.90M	1.55%
Apr 17, 2024	936.40M	1.02%
Apr 16, 2024	926.90M	0.19%
Apr 15, 2024	925.10M	-1.99%
Apr 12, 2024	943.90M	-
Apr 11, 2024	943.90M	-2.54%
Apr 10, 2024	968.50M	3.39%
Apr 9, 2024	936.70M	-1.36%
Apr 8, 2024	949.60M	1.55%
Apr 5, 2024	935.10M	-0.45%
Apr 4, 2024	939.30M	-
Apr 3, 2024	939.30M	6.41%
Apr 2, 2024	882.70M	0.50%
Apr 1, 2024	878.30M	-2.31%
Mar 28, 2024	899.10M	-3.31%
Mar 27, 2024	929.90M	-0.33%
Mar 26, 2024	933.00M	3.63%
Mar 25, 2024	900.30M	-1.99%
Mar 22, 2024	918.60M	-1.08%

View and export this data all the way back to 2023. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Cullinan Oncology	1.08B
AbCellera Biologics	1.08B
Immatics	1.03B
Maravai LifeSciences Holdings	1.02B
Silence Therapeutics	1.00B
Cronos Group	999.00M
Arcutis Biotherapeutics	996.22M
Alignment Healthcare	991.42M

Market Cap Rankings